IP Library › Granted Patent US 10,555,914
Granted Patent B1
US 10,555,914 · App. 16/440,878 · Granted Feb 11, 2020

Methods of producing anionic cannabinoid molecules dissolved in water

Inventor: Douglas G. Metcalf (Erie, CO)
Assignee: Natural Extraction Systems, LLC
A61K31/05A61K9/0095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,555,914
App. No.
16/440,878
Granted
Feb 11, 2020
Kind
B1
Abstract

Various aspects of this patent document relate to methods to produce compositions comprising anionic cannabinoid molecules.

Claims (37)

1. A method to solubilize a cannabinoid in water, comprising:

providing a cannabinoid molecule, the cannabinoid molecule is cannabidiol and comprises an aromatic ring and a hydroxyl group, and the hydroxyl group is a substituent on the aromatic ring;

providing a Brønsted base and ethanol;

providing water;

contacting the cannabinoid molecule with the Brønsted base and the ethanol to deprotonate the hydroxyl group and to produce an anionic cannabinoid molecule; and

dissolving the anionic cannabinoid molecule in the water to produce a solution comprising the anionic cannabinoid molecule;

the solution comprising the anionic cannabinoid molecule has a pH of at least 8.5; and the anionic cannabinoid molecule is selected from the group consisting of:

2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate; 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-3-en-1-yl]-3-hydroxy-5-pentylphenolate; 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone-3-oxide;

3-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-6-pentyl-1,2-benzoquinone-4-oxide;

2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-3-en-1-yl]-5-pentyl-1,4-benzoquinone-3-oxide;

3-[(1R,6R)-6-isopropenyl-3-methylcyclohex-3-en-1-yl]-6-pentyl-1,2-benzoquinone-4-oxide; and

(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-oxide.

2. The method of claim 1 , in which the cannabinoid molecule is cannabidiol, and the anionic cannabinoid molecule is 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate.

3. The method of claim 1 , in which the Brønsted base is ethoxide or hydroxide.

4. The method of claim 1 , which either (i) the cannabinoid molecule, (ii) the Brønsted base, or (iii) both the cannabinoid molecule and the Brønsted base are dissolved in a solvent when the cannabinoid molecule and the Brønsted base are contacted with each other.

5. The method of claim 4 , in which the solvent is ethanol.

6. The method of claim 5 , which the solution has an ethanol concentration, and the method comprises adjusting the ethanol concentration of the solution to an ethanol concentration no greater than 0.05% by weight.

7. The method of claim 4 , in which the solvent has a dissolved oxygen concentration, and the method comprises reducing the dissolved oxygen concentration of the solvent prior to contacting the cannabinoid molecule with the Brønsted base.

8. The method of claim 1 , which the water has a dissolved oxygen concentration, and the method comprises reducing the dissolved oxygen concentration of the water prior to dissolving the anionic cannabinoid molecule in the water.

9. The method of claim 1 , in which the water has a pH, and the pH is greater than 9.5.

10. The method of claim 1 , in which the solution comprising the anionic cannabinoid molecule has a pH, and the method comprises adjusting the pH to 8.5 to 10.5.

11. The method of claim 1 , comprising adjusting a concentration of the anionic cannabinoid molecule in the solution to a concentration of 20 micrograms per liter to 2000 milligrams per liter.

12. The method of claim 1 , in which the method results in a lipid phase in fluid communication with the solution comprising the anionic cannabinoid molecule, and the method comprises separating the lipid phase from the solution.

13. The method of claim 1 , comprising inserting the solution comprising the anionic cannabinoid molecule into a container and then hermetically-sealing the container.

14. The method of claim 13 , comprising inserting 25 milliliters to 800 milliliters of the solution into the container.

15. The method of claim 13 , comprising transferring ownership of the container and receiving payment for transferring ownership of the container.

16. The method of claim 1 , in which:

the cannabinoid molecule is cannabidiol;

the anionic cannabinoid molecule is 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate;

the Brønsted base is dissolved in a solvent when the cannabinoid molecule and the Brønsted base are contacted with each other;

the solvent is ethanol;

the Brønsted base is hydroxide or ethoxide;

the water has a pH;

the pH of the water is greater than 9.5;

the solution comprising the anionic cannabinoid molecule has a pH;

either the pH of the solution is 8.5 to 10.5, or the method comprises adjusting the pH of the solution to 8.5 to 10.5; and

the method comprises inserting the solution comprising the anionic cannabinoid molecule into a container and then hermetically-sealing the container.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: METCALF, DOUGLAS G.
To: NATURAL EXTRACTION SYSTEMS, LLC
Reel/Frame 050107/0602 →
Continuity (3)
Provisional Application 62780176 · Dec 14, 2018
Provisional Application 62787720 · Jan 2, 2019
Provisional Application 62812845 · Mar 1, 2019
Cited By (4)
US 12,290,542 US 12,349,706 US 12,390,418 US 12,484,606